FIELD: medicine.
SUBSTANCE: method involves using blood hemolysate as special purpose product. Sodium succinate is dissolved in phosphate buffer solution. Nitro-BT is added as hydrogen acceptor that transforms into nitro-diformazane. Supernatant liquid is centrifuged and succinate dehydrogenase activity is determined.
EFFECT: high accuracy in determining enzyme activity.
2 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF IMMUNITY ASSESSMENT | 2007 |
|
RU2371727C2 |
| METHOD OF DETERMINING RELATIVE ACTIVITY OF DEHYDROGENASES IN BLOOD LEUKOCYTES | 0 |
|
SU1320751A1 |
| METHOD OF DIAGNOSIS OF PYELONEPHRITIS ACUTE STAGE | 1994 |
|
RU2115124C1 |
| METHOD FOR PREDICTION OF RECURRENT ACETONEMIC VOMITING IN CHILDREN | 2011 |
|
RU2481576C1 |
| METHOD FOR DETERMINING AN OPTIMAL CRYOPROTECTOR ACCORDING TO A CYTOCHEMICAL INDICATOR OF CONTENT OF SUCCINATE DEHYDROGENASE IN BLOOD PLASMA LEUKOCYTES | 2017 |
|
RU2689328C1 |
| METHOD FOR DIAGNOSING MYASTHENIA | 1998 |
|
RU2138811C1 |
| METHOD FOR PREDICTING BODY STATE IN NEONATALS | 2003 |
|
RU2265850C2 |
| METHOD OF DETERMINING INSULIN RESISTANCE OF IMMUNOGENESIS IN PATIENTS WITH TYPE 1 DIABETES MELLITUS | 0 |
|
SU1767433A1 |
| METHOD OF PREDICTING PEPTIC ULCER RUN | 0 |
|
SU1772762A1 |
| METHOD FOR PREDICTING THE COURSE OF CHRONIC GENOTYPE 1 HEPATITIS C IN UNTREATED PATIENTS WITH HIGH VIRAL LOAD | 2017 |
|
RU2657586C1 |
